Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+10.43%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$66.5B
AUM Growth
+$7.54B
Cap. Flow
+$3.26B
Cap. Flow %
4.91%
Top 10 Hldgs %
11.06%
Holding
4,024
New
580
Increased
1,559
Reduced
1,325
Closed
540

Sector Composition

1 Technology 19.7%
2 Healthcare 16.66%
3 Consumer Discretionary 13.03%
4 Industrials 9.61%
5 Financials 9.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EBR icon
3001
Eletrobras Common Shares
EBR
$19.1B
$283K ﹤0.01%
39,100
-21,000
-35% -$152K
ALXO icon
3002
ALX Oncology
ALXO
$62.7M
$283K ﹤0.01%
155,300
-282,900
-65% -$515K
VRAX icon
3003
Virax Biolabs
VRAX
$2.52M
$282K ﹤0.01%
145,400
+134,399
+1,222% +$261K
AVDL
3004
Avadel Pharmaceuticals
AVDL
$1.54B
$282K ﹤0.01%
21,500
-42,896
-67% -$563K
VWO icon
3005
Vanguard FTSE Emerging Markets ETF
VWO
$100B
$281K ﹤0.01%
5,870
-26,039
-82% -$1.25M
EBON icon
3006
Ebang International Holdings
EBON
$25.8M
$281K ﹤0.01%
46,613
+900
+2% +$5.42K
SCOR icon
3007
Comscore
SCOR
$31.6M
$281K ﹤0.01%
41,321
-4,014
-9% -$27.3K
SBFG icon
3008
SB Financial Group
SBFG
$136M
$278K ﹤0.01%
13,525
-1,700
-11% -$35K
TRIB
3009
Trinity Biotech
TRIB
$4.32M
$275K ﹤0.01%
250,153
-15,300
-6% -$16.8K
LYEL icon
3010
Lyell Immunopharma
LYEL
$251M
$272K ﹤0.01%
9,870
+2,255
+30% +$62.2K
VCR icon
3011
Vanguard Consumer Discretionary ETF
VCR
$6.57B
$272K ﹤0.01%
800
-1,101
-58% -$375K
MTA
3012
Metalla Royalty & Streaming
MTA
$511M
$271K ﹤0.01%
87,600
+3,300
+4% +$10.2K
SMID icon
3013
Smith-Midland
SMID
$215M
$270K ﹤0.01%
8,100
-2,600
-24% -$86.8K
WVVI icon
3014
Willamette Valley Vineyards
WVVI
$25.2M
$270K ﹤0.01%
77,652
-2,300
-3% -$8K
BITU icon
3015
ProShares Ultra Bitcoin ETF
BITU
$1.17B
$269K ﹤0.01%
+10,400
New +$269K
NREF
3016
NexPoint Real Estate Finance
NREF
$268M
$269K ﹤0.01%
17,200
-1,300
-7% -$20.3K
CREX icon
3017
Creative Realities
CREX
$24M
$269K ﹤0.01%
58,502
+3,400
+6% +$15.6K
CUZ icon
3018
Cousins Properties
CUZ
$4.91B
$268K ﹤0.01%
9,100
-20,031
-69% -$591K
KRMD icon
3019
KORU Medical Systems
KRMD
$186M
$268K ﹤0.01%
+98,100
New +$268K
SCPH icon
3020
scPharmaceuticals
SCPH
$301M
$267K ﹤0.01%
58,656
-162,344
-73% -$740K
TBI
3021
Trueblue
TBI
$171M
$267K ﹤0.01%
33,900
-116,700
-77% -$921K
FGBI icon
3022
First Guaranty Bancshares
FGBI
$126M
$267K ﹤0.01%
25,106
+9,791
+64% +$104K
EQ icon
3023
Equillium
EQ
$118M
$267K ﹤0.01%
321,173
+20,773
+7% +$17.3K
DEM icon
3024
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.19B
$266K ﹤0.01%
6,047
-3,053
-34% -$134K
BHM icon
3025
Bluerock Homes Trust
BHM
$52M
$266K ﹤0.01%
17,800